Breast cancer vaccine (Quantum Immunologics)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBreast cancer vaccine (Quantum Immunologics)

Drug Alias Name乳腺癌疫苗 - Quantum ImmunologicsOFA/iLRP-loaded autologous monocyte-derived dendritic cells

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of South Alabama (Usa)

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesQuantum Immunologics Inc

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A